CBD Transdermal Patches

Buy CBD Patches. Coming Soon! 


Novagant Corp. Announces Breakthrough in Cannabidiol (CBD) Transdermal Patch for Localized Delivery

DENVER, CO--(Marketwired - October 29, 2014) - Novagant Corp. (PINKSHEETS: NVGT) is pleased to announce that it has found the best carrier for the localized delivery of Cannabidiol (CBD).

The challenges have been mainly the low absorption rate of the carrier oil.

By avoiding the effects on the gastrointestinal tract and first-pass metabolism seen with some oral delivery, transdermal patch therapies can enhance therapeutic efficacy while decreasing side effects. Transdermal patches can do localized delivery to the exact spot where the Cannabinoids (CBD) are needed. Transdermal delivery also prevents the metabolization of THC into your fatty tissues, even though the legal industrial hemp oil contains a very small amount of THC (less than 1% by volume). Cannabidiol (CBD) is a non-psychoactive component of Cannabis (aka Hemp) that has therapeutic benefits without the feeling of being "stoned" or "high."

The new patch formula will be based on the GoldenCBD™ oil extract.

GoldenCBD™ is 100% natural and derived from the federally-legal industrial hemp plant. Our unique hemp cultivars, combined with our proprietary technologies, produce the highest quality CBD-rich hemp oil in the world.

Investor Updates:

Novagant Corp. is 90 days away from its first test batch of patches for internal testing.

Version 2 of the AlKanna LED with "grow-by-number" technology is nearing completion.

Novagant Corp. is also developing a new line of industrial standard LED lighting fixtures.

About Novagant Corp.:
Novagant Corp. was incorporated in the state of Nevada on February 23, 1987 under the name of Kendrex Systems, Inc. The Company underwent several name changes, and ultimately on November 26, 2013 changed its name to Novagant Corp. For more information about the Company, please visit www.novagant.com.

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Comments